Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?

详细信息    查看全文

• 作者：Tavey Dorofaeff ; MBChB ; FRACP ; FCICM¹ ; ² ; Rossella M. Bandini ; BSc (Hons)³ ; ⁴ ; Jeffrey Lipman ; MBBCh ; DA ; FFA ; FCICM ; MD¹ ; ⁴ ; ⁵ ; ⁶ ; Daynia E. Ballot ; MBBCh ; FCPaed ; SA ; PhD⁴ ; ⁷ ; Jason A. Roberts ; PhD ; BPharm (Hons) ; FSHP¹ ; ⁵ ; ⁸ ; ⁹ ; Suzanne L. Parker ; PhD ; GDipComm ; BSc (Chem)¹ ; ^{suzanne.parker@uq.edu.au" class="auth_mail" title="E-mail the corresponding author}
• 关键词：antibiotic ; microsampling ; pharmacokinetic
• 刊名：Clinical Therapeutics
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：38
• 期：9
• 页码：1961-1975
• 全文大小：407 K

文摘

With a decreasing supply of antibiotics that are effective against the pathogens that cause sepsis, it is critical that we learn to use currently available antibiotics optimally. Pharmacokinetic studies provide an evidence base from which we can optimize antibiotic dosing. However, these studies are challenging in critically ill neonate and pediatric patients due to the small blood volumes and associated risks and burden to the patient from taking blood. We investigate whether microsampling, that is, obtaining a biologic sample of low volume (<50 μL), can improve opportunities to conduct pharmacokinetic studies.

Methods

We performed a literature search to find relevant articles using the following search terms: sepsis, critically ill, severe infection, intensive care AND antibiotic, pharmacokinetic, p(a)ediatric, neonate. For microsampling, we performed a search using antibiotics AND dried blood spots OR dried plasma spots OR volumetric absorptive microsampling OR solid-phase microextraction OR capillary microsampling OR microsampling. Databases searched include Web of Knowledge, PubMed, and EMbase.

Findings

Of the 32 antibiotic pharmacokinetic studies performed on critically ill neonate or pediatric patients in this review, most of the authors identified changes to the pharmacokinetic properties in their patient group and recommended either further investigations into this patient population or therapeutic drug monitoring to ensure antibiotic doses are suitable. There remain considerable gaps in knowledge regarding the pharmacokinetic properties of antibiotics in critically ill pediatric patients. Implementing microsampling in an antibiotic pharmacokinetic study is contingent on the properties of the antibiotic, the pathophysiology of the patient (and how this can affect the microsample), and the location of the patient. A validation of the sampling technique is required before implementation.

Implications

Current antibiotic regimens for critically ill neonate and pediatric patients are frequently suboptimal due to a poor understanding of altered pharmacokinetic properties.

An assessment of the suitability of microsampling for pharmacokinetic studies in neonate and pediatric patients is recommended before wider use. The method of sampling, as well as the method of bioanalysis, also requires validation to ensure the data obtained reflect the true result.